To compare the immunogenicity and protective activity of linear and circular mRNA vectors, specifically focusing on different capping types (ARCA and CleanCap) and IRES configurations (coxsackievirus B3 and human rhinovirus B6).
Key Findings:
Modified linear vectors showed significantly higher expression levels in vitro and in vivo compared to circular vectors, indicating a potential advantage in vaccine development.
Immunogenicity and protective activity of circular vectors were comparable to linear vectors in active immunization studies, suggesting their viability as alternatives.
Linear vectors provided significantly better protection than circular vectors in passive immunization models, correlating with their higher protein expression levels.
Interpretation:
Higher expression levels of linear mRNA vectors did not translate to superior immunogenicity or protection in active immunization, but were advantageous in passive immunization scenarios requiring high protein expression.
Limitations:
The study primarily focused on specific configurations of mRNA vectors and may not encompass all possible variations, which could limit the generalizability of the findings.
Limited exploration of the full range of IRESes and their effects on immunogenicity may overlook important factors influencing vector efficacy.
Conclusion:
While linear mRNA vectors demonstrate higher expression levels, both vector types have their roles in immunization strategies, with linear vectors being preferable for passive immunization scenarios, highlighting the need for tailored approaches in vaccine design.
by Vladimir M. Vakhtinskii, Irina L. Tutykhina, Alina S. Dzharullaeva, Daria M. Grousova, Ilya D. Zorkov, Anna A. Ilyukhina, Dmitrii A. Reshetnikov, Valentin V. Azizyan, Artem A. Derkaev, Evgeniia N. Bykonia, Evgeny V. Usachev, Denis A. Kleymenov, Vladimir A. Gushchin, Inna V. Shuliakova, Dmitry V. Shcheblyakov, Maxim M. Shmarov, Denis Yu. Logunov, Alexander L. Gintsburg
